Subclinical atherosclerosis among rheumatoid arthritis patients without overt cardiovascular risk factors

Modern Rheumatology

Volumn 24, Issue 6, 2014, Pages 920-925

  Sahari, Narisa Sulaiman ^a   Shaharir, Syahrul Sazliyana ^b   Ismail, Mohd Redzuan ^b   Rajalingham, Sakthiswary ^b   Said, Mohd Shahrir Mohamed ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Atherosclerosis; Carotid intima media thickness; Disease activity; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CYCLOSPORIN A; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SUBCLINICAL ATHEROSCLEROSIS; CAROTID ARTERY; COMPLICATION; ECHOGRAPHY; MIDDLE AGED; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ADULT; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84932141866     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2014.891497     Document Type: Article

References (50)

1. Brady SR. dc Courten B. Reid CM. Cicuttini FM, de Courten MP, Liew D. The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis. J Rheumatol. 2009:36(1):34-40.
2. Solomon DH, Kremer J, Curtis JR, Hochberg MC, Reed G, Tsao P. et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis. 2010;69(11): 1920-5.
3. Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med. 2008:121:S9-14.
4. Meune C. Touzé E. Trinquart L. Allanore Y. High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis. 2010;103:253-61.
5. Gonzalez-Gay MA, Gonzalez-Juanatey C, Miranda-Filloy JA, Garcia-Porrua C, Llorca J, et al. Cardiovascular disease in rheumatoid arthritis. Biomed Pharmacother. 2006;60:673-677.
6. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM. Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59(12): 1690-7.
7. Solomon DH, Goodson NJ, Katz JN, Weinblatt ME. Avorn J, Setoguchi S, et al. Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis. 2006;65(12):1608-12.
8. Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med. 2008;121 (l0 Suppl l):S3-8.
9. Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med. 2008:121(10 Suppl 1):S21-31.
10. Ozbalkan Z, Ete C, Cesur M, Ertek S, Nasiroglu N, Berneis K, Rizzo M. An update on the relationship between rheumatoid arthritis and atherosclerosis. Atherosclerosis. 2010;212(2):377-82.
11. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685-95.
12. Gabriel SE, Crowson CS. Risk factors for cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol. 2012;24(2): 171-6.
13. Goodson NJ, Symmons DP, Scott DG. Bunn D. Lunt M, Silman AJ. Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum. 2005;52(8):2293-9.
14. Wallberg-Jonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol. 1997;24(3):445-51.
15. Stein JH. Korcarz CE. Hurst RT, Lonn E, Kendall CB, Mohler ER. et al.; American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93-112.
16. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol. 2001:12(11):2458-64.
17. Park YB. Ahn CW. Choi HK. Lee SH, In BH, Lee HC, et al. Atherosclerosis in rheumatoid arthritis: Morphologic evidence obtained by carotid ultrasound. Arthritis Rheum. 2002;46(7):1714-9.
18. Gonzalez-Juanatey C, Llorca J, Testa A, Revuelta J, Garcia-Porrua C, Gonzalez-Gay MA. Increase prevalence of severe subclinical atherosclerosis findings in long term treated rheumatoid arthritis without clinically evidence atherosclerotic disease. Medicine(Baltimore).2003; 82(6):407-13.
19. Ristić GG, Lepić T, Glisić B, Stanisavljević D, Vojvodić D, Petronijević M, Stefanović D. Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment. Rheumatology (Oxford). 2010:49(6): 1076-81.
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31 (3):315-24.
21. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT. Bingham CO III, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569-81.
22. Fleiss JL. Statistical Methods for Rates and Proportions. New York: John Wiley and Sons; 1981.
23. Fransen J, Creemers MC, Van Riel PL. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford). 2004;43(10): 1252-5.
24. Georgiadis AN, Voulgari PV, Argyropoulou MI, Alamanos Y, Elisaf M, Tselepis AD, Drosos AA. Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients. Semin Arthritis Rheum. 2008;38(1): 13-9.
25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461-70.
26. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008:21 (2):93-111; quiz 89-90.
27. O’Leary DH, Polak JF, Kronmal RA. Manolio TA, Burke GL. Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999:340(1): 14-22.
28. Farzaneh-Far A, Roman MJ. Accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Int J Clin Pract. 2005:59(7): 823-4
29. Peters MJL, van Halm VP, Voskuyl AE, Smulders YM, Boers M, Lems WF, et al. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Care Res (Hoboken). 2009:61(11): 1571-9.
30. Hannawi S, Haluska B, Marwick TH, Thomas R. Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther. 2007;9(6):R116.
31. Del Rincon I, Williams K, Stern MP. Freeman GL. O'Leary DH, Escalante A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum. 2003:48(7): 1833-40.
32. Roman MJ. Moeller E. Davis A, Paget SA, Crow MK. Lockshin MD, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med. 2006;144(4):249-56.
33. Park YB, Ahn CW, Choi HK. Lee SH. In BH. Lee HC, et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum. 2002;46(7):1714-9.
34. Targonska-Stepniak B, Drelich-Zbroja A, Majdan M. The relationship between carotid intima-media thickness and the activity of rheumatoid arthritis. J Clin Rheumatol. 2011:17 (5):249-55.
35. Singh H, Goyal Mukesh, Sen J, Kumar H, Handa R, Garg S. Correlation of intima media thickness with activity and duration of rheumatoid arthritis using carotid ultrasound. JIACM. 2011; 12(1): 15-20.
36. van Sijl AM, Peters MJ, Knol DK, de Vet HC, Gonzalez-Gay MA. Smulders YM, et al. Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum. 2011:40(5):389-97.
37. Mahajan V, Handa R, Kumar U, Sharma S, Gulati G, Pandey RM, Lakshmy R. Assessment of atherosclerosis by carotid intimomedial thickness in patients with rheumatoid arthritis. J Assoc Physicians India. 2008:56:587-90.
38. Juonala M, Kahonen M, Laitinen T, Hutri-Kahonen N, Jokinen E, Taittonen L, et al. Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: the cardiovascular risk in Young Finns Study. Eur Heart J. 2008;29(9):1198-206.
39. Del Porto F, Laganà B. Lai S, Nofroni I. Tinti F. Vitale M. et al. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology. 2007 (46):111-5.
40. Chatteijee Adhikari M. Guin A, Chakraborty S, Sinhamahapatra P. Ghosh A. Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Semin Arthritis Rheum. 2012;41(5):669-75.
41. Gerli R. Bartoloni Bocci E. Sherer Y. Vaudo G, Moscatelli S, Shoenfeld Y. Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67(5):724-5.
42. Van Doomum S, McColl G, Jenkins A, Green DJ. Wicks IP. Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum. 2003;48(I):72-80.
43. Cooper RS. Kaufman JS. Ward R. Race and genomics. N Engl J Med. 2003;348(12): 1166-70.
44. Kullcr LH. Ethnic differences in atherosclerosis, cardiovascular disease and lipid metabolism. Curr Opin Lipidol. 2004; 15(2): 109-13.
45. Emmanuel SC. Trends in coronary heart disease mortality in Singapore. Singapore Med J. 1989;30(1): 17-23.
46. Gonzalez-Juanatey C. Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J. Vidan J. et al. HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med. 2003; 114(8):647-52.
47. Farragher TM. Goodson NJ. Naseem H, Silman AJ. Thomson W, Symmons D. Barton A. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory- polyarthritis. Arthritis Rheum. 2008;58(2):359-69.
48. Rodriguez-Rodriguez L, Lopez-Mejias R, Garcia-Bermudez M, GonzalezrJuanatey C. Gonzalez-Gay MA, Martin J. Genetic markers of cardiovascular disease in rheumatoid arthritis. Mediators Inflamm. 2012;2012:574817.
49. Ferrante A, Giardina AR. Ciccia F. Parrinello G, Licata G, Avellone G, et al. Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis. Rheumatol Int. 2009;30(2): 193-8.
50. Bamabc C. Martin BJ. Ghali WA. Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2011:63(4): 522-9.